Advanced Imaging Techniques Offer Potential to Reduce Unnecessary Prostate Biopsies

Prostate cancer diagnosis traditionally depends on elevated prostate-specific antigen (PSA) levels and subsequent biopsies. However, recent research from the Medical University of Vienna indicates that specialized imaging technology might reduce the frequency of unnecessary biopsies.

This innovative imaging technique, PSMA-PET/CT, was analyzed in a study involving 194 men, where it demonstrated a 91% detection rate for clinically significant prostate cancers. These findings, led by Marcus Hacker, the Head of the Division of Nuclear Medicine at the Department of Biomedical Imaging and Image-guided Therapy, were published in the inaugural issue of The Lancet Medical Imaging & Theranostics.

PSMA-PET/CT employs two complementary methods—positron emission tomography (PET) and computed tomography (CT)—to detect prostate cancer effectively. PET utilizes a small dose of radioactive material that binds to the prostate-specific membrane antigen (PSMA), a protein prevalent in prostate cancer cells, thereby identifying abnormal areas. At the same time, CT offers precise anatomical localization through detailed imagery.

The study also assessed the use of PSMA-PET/CT in the context of the Phase 3 RAPID trial. Among the 77 patients confirmed to have notable prostate cancer through biopsy, 70 cases were identified using PSMA-PET/CT, affirming its high detection capability. Moreover, the method displayed a high predictive value; in cases yielding a normal scan result, 91% of subjects were correctly predicted not to have clinically significant tumors.

During a median follow-up of 35 months, it was found that PSMA-PET/CT had identified 23 of the 24 patients who subsequently developed aggressive forms of the disease. This underscores the potential of the imaging technology in anticipating the course of prostate cancer.

The results posit that PSMA-PET/CT could enhance the early diagnostic process, helping determine which patients truly require biopsies. This approach may reduce the need for invasive procedures. Further investigation is necessary to integrate this technique into standard clinical practice, evaluating its efficacy and practicality.

"Our research demonstrates that PSMA-PET/CT might provide crucial early diagnostic insights. The significance of detecting a normal result is pertinent in deciding the necessity of a biopsy for a patient," states Marcus Hacker.